Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Dietary Flavonol Intake Linked to Reduced Risk of Alzheimer’s

Key clinical point: Dietary intake of flavonols through leafy greens and other vegetables or fruits was inversely associated with risk of developing Alzheimer’s disease (AD).

Major finding: The rate of developing AD was 48% lower among participants reporting the highest total dietary intake of flavonols, compared with those reporting the lowest intake.

Study details: Study of 921 participants in the Rush Memory and Aging Project, a large, prospective study of older individuals in retirement communities and public housing in the Chicago area that has been ongoing since 1997.

Disclosures: The study was funded by grants from the National Institutes of Health and the USDA Agricultural Research Service. The authors said they had no disclosures relevant to their report.

Citation:

Holland TM et al. Neurology. 2020 Jan 29. doi: 10.1212/WNL.0000000000008981.